SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

SEC Comment Letter 0000000000-23-003750 to Solowin Holdings, Ltd. (SWIN) (CIK 0001959224) (AXG)

Solowin Holdings, Ltd. (SWIN) (CIK 0001959224)
Date: April 14, 2023 · CIK: 0001959224 · Accession: 0000000000-23-003750

AI Filing Summary & Sentiment

Date
April 14, 2023
Author
Office of Finance
Form
UPLOAD
Company
Solowin Holdings, Ltd. (SWIN) (CIK 0001959224)

Letter

United States securities and exchange commission logo April 14, 2023 Thomas Tam Chief Executive Officer Solowin Holdings, Ltd. Room 1910-1912A, Tower 3 China Hong Kong City 33 Canton Road Tsim Sha Tsui, Kowloon Hong Kong Re:Solowin Holdings, Ltd. Amendment No. 2 to Draft Registration Statement on Form F-1 Submitted March 29, 2023 CIK No. 0001959224 Dear Thomas Tam: We have reviewed your amended draft registration statement and have the following comments. In some of our comments, we may ask you to provide us with information so we may better understand your disclosure. Please respond to this letter by providing the requested information and either submitting an amended draft registration statement or publicly filing your registration statement on EDGAR. If you do not believe our comments apply to your facts and circumstances or do not believe an amendment is appropriate, please tell us why in your response. After reviewing the information you provide in response to these comments and your amended draft registration statement or filed registration statement, we may have additional comments. Amendment No. 2 to Draft Registration Statement on Form F-1 filed March 29, 2023 Prospectus Cover Page, page i 1.We note your response to comment 1 and reissue in part. Please revise here, and in the prospectus summary and risk factors, to clarify that the legal and operational risks associated with operations in China may also apply to your operations in Hong Kong, should recent statements and regulatory actions by China’s government apply to you in the future.

FirstName LastNameThomas Tam Comapany NameSolowin Holdings, Ltd. April 14, 2023 Page 2 FirstName LastName Thomas Tam Solowin Holdings, Ltd. April 14, 2023 Page 2 Commonly Used Defined Terms, page ii 2.We note your response to comment 2 and reissue. We further note that (i) this document continues to contain references to “we,” “us,” “our,” "the Company" and “our company” throughout and (ii) your disclosure on page i indicates that terms such as “we,” “us,” “our”, "the Company" and “our company” may refer to Solowin Holdings and its subsidiary, Solomon JZ, as a whole or may refer to just Solomon JZ, where disclosures pertain to business operations. Please refrain from using terms such as “we,” “us,” “our,” “our company,” and “our business” when describing activities or functions of the operating subsidiary. Please revise disclosures throughout the document as necessary to provide distinct references for the holding company, subsidiary, and other entities so that it is clear to investors which entity the disclosure is referencing and which subsidiaries or entities are conducting the business operations. You may contact Shannon Davis at (202) 551-6687 or John Spitz at (202) 551-3484 if you have questions regarding comments on the financial statements and related matters. Please contact Robert Arzonetti at (202) 551-8819 or Susan Block at (202) 551-3210 with any other questions. Sincerely, Division of Corporation Finance Office of Finance cc: Kevin Sun

Show Raw Text
United States securities and exchange commission logo
April 14, 2023
Thomas Tam
Chief Executive Officer
Solowin Holdings, Ltd.
Room 1910-1912A, Tower 3
China Hong Kong City
33 Canton Road
Tsim Sha Tsui, Kowloon
Hong Kong
Re:Solowin Holdings, Ltd.
Amendment No. 2 to Draft Registration Statement on Form F-1
Submitted March 29, 2023
CIK No. 0001959224
Dear Thomas Tam:
            We have reviewed your amended draft registration statement and have the following
comments.  In some of our comments, we may ask you to provide us with information so we
may better understand your disclosure.
            Please respond to this letter by providing the requested information and either submitting
an amended draft registration statement or publicly filing your registration statement on
EDGAR.  If you do not believe our comments apply to your facts and circumstances or do not
believe an amendment is appropriate, please tell us why in your response.
            After reviewing the information you provide in response to these comments and your
amended draft registration statement or filed registration statement, we may have additional
comments.
Amendment No. 2 to Draft Registration Statement on Form F-1 filed March 29, 2023
Prospectus Cover Page, page i
1.We note your response to comment 1 and reissue in part. Please revise here, and in the
prospectus summary and risk factors, to clarify that the legal and operational risks
associated with operations in China may also apply to your operations in Hong Kong,
should recent statements and regulatory actions by China’s government apply to you in
the future.

 FirstName LastNameThomas Tam
 Comapany NameSolowin Holdings, Ltd.
 April 14, 2023 Page 2
 FirstName LastName
Thomas Tam
Solowin Holdings, Ltd.
April 14, 2023
Page 2
Commonly Used Defined Terms, page ii
2.We note your response to comment 2 and reissue. We further note that (i) this document
continues to contain references to “we,” “us,” “our,” "the Company" and “our
company” throughout and (ii) your disclosure on page i indicates that terms such as “we,”
“us,” “our”, "the Company" and “our company” may refer to Solowin Holdings and its
subsidiary, Solomon JZ, as a whole or may refer to just Solomon JZ, where disclosures
pertain to business operations. Please refrain from using terms such as “we,” “us,” “our,”
“our company,” and “our business” when describing activities or functions of the
operating subsidiary. Please revise disclosures throughout the document as necessary to
provide distinct references for the holding company, subsidiary, and other entities so that
it is clear to investors which entity the disclosure is referencing and which subsidiaries or
entities are conducting the business operations.
            You may contact Shannon Davis at (202) 551-6687 or John Spitz at (202) 551-3484 if
you have questions regarding comments on the financial statements and related matters.  Please
contact Robert Arzonetti at (202) 551-8819 or Susan Block at (202) 551-3210 with any other
questions.
Sincerely,
Division of Corporation Finance
Office of Finance
cc:       Kevin Sun